pI: 6.7581 |
Length (AA): 669 |
MW (Da): 72610 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 668 | 1gpu (A) | 5 | 680 | 48.00 | 0 | 1 | 1.63791 | -0.96 |
4 | 667 | 1r9j (A) | 3 | 666 | 64.00 | 0 | 1 | 1.86343 | -1.56 |
5 | 648 | 4c7v (A) | 6 | 658 | 45.00 | 0 | 1 | 1.60683 | -1.23 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_126720)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G45290 | transketolase |
Arabidopsis thaliana | AT3G60750 | transketolase |
Brugia malayi | Bm1_10280 | transketolase |
Candida albicans | CaO19.12578 | transketolase 1 |
Candida albicans | CaO19.5112 | transketolase 1 |
Caenorhabditis elegans | CELE_F01G10.1 | Protein TKT-1 |
Chlamydia trachomatis | CT_750 | transketolase |
Dictyostelium discoideum | DDB_G0272618 | hypothetical protein |
Dictyostelium discoideum | DDB_G0274019 | hypothetical protein |
Drosophila melanogaster | Dmel_CG8036 | CG8036 gene product from transcript CG8036-RB |
Drosophila melanogaster | Dmel_CG5103 | CG5103 gene product from transcript CG5103-RA |
Escherichia coli | b2465 | transketolase 2, thiamine triphosphate-binding |
Escherichia coli | b2935 | transketolase 1, thiamine triphosphate-binding |
Echinococcus granulosus | EgrG_000103100 | transketolase |
Echinococcus granulosus | EgrG_000103400 | transketolase |
Entamoeba histolytica | EHI_011410 | transketolase, putative |
Entamoeba histolytica | EHI_157770 | transketolase, putative |
Entamoeba histolytica | EHI_002160 | transketolase, putative |
Entamoeba histolytica | EHI_177870 | transketolase, putative |
Echinococcus multilocularis | EmuJ_000103400 | transketolase |
Echinococcus multilocularis | EmuJ_000103100 | transketolase |
Giardia lamblia | GL50803_9704 | Transketolase |
Homo sapiens | ENSG00000163931 | transketolase |
Homo sapiens | ENSG00000151005 | transketolase-like 2 |
Homo sapiens | ENSG00000007350 | transketolase-like 1 |
Leishmania braziliensis | LbrM.24.2140 | transketolase |
Leishmania donovani | LdBPK_242150.1 | transketolase |
Leishmania infantum | LinJ.24.2150 | transketolase |
Leishmania major | LmjF.24.2060 | transketolase |
Leishmania mexicana | LmxM.24.2060 | transketolase, putative |
Loa Loa (eye worm) | LOAG_01391 | hypothetical protein |
Mycobacterium leprae | ML0583c | Probable transketolase Tkt (TK) |
Mus musculus | ENSMUSG00000031397 | transketolase-like 1 |
Mus musculus | ENSMUSG00000025519 | transketolase-like 2 |
Mus musculus | ENSMUSG00000021957 | transketolase |
Mycobacterium tuberculosis | Rv1449c | Transketolase Tkt (TK) |
Mycobacterium ulcerans | MUL_1844 | transketolase |
Neospora caninum | NCLIV_011210 | Transketolase, related |
Oryza sativa | 4335330 | Os04g0266900 |
Oryza sativa | 4340025 | Os06g0133800 |
Plasmodium berghei | PBANKA_0109100 | transketolase, putative |
Plasmodium falciparum | PF3D7_0610800 | transketolase |
Plasmodium knowlesi | PKNH_1139600 | transketolase, putative |
Plasmodium vivax | PVX_113675 | transketolase, putative |
Plasmodium yoelii | PY03111 | transketolase |
Saccharomyces cerevisiae | YPR074C | transketolase TKL1 |
Saccharomyces cerevisiae | YBR117C | transketolase TKL2 |
Schistosoma japonicum | Sjp_0211850 | ko:K00615 transketolase [EC2.2.1.1], putative |
Schistosoma mansoni | Smp_059790.2 | transketolase |
Schistosoma mansoni | Smp_059790.1 | transketolase |
Schmidtea mediterranea | mk4.000601.01 | |
Schmidtea mediterranea | mk4.000601.05 | |
Schmidtea mediterranea | mk4.002944.03 | |
Schmidtea mediterranea | mk4.000601.00 | |
Trypanosoma brucei gambiense | Tbg972.8.6230 | transketolase, putative |
Trypanosoma brucei | Tb927.8.6170 | transketolase, putative |
Trypanosoma congolense | TcIL3000_8_6020 | transketolase, putative |
Trypanosoma cruzi | TcCLB.511903.120 | transketolase, putative |
Trypanosoma cruzi | TcCLB.511067.30 | transketolase, putative |
Toxoplasma gondii | TGME49_318310 | transketolase |
Treponema pallidum | TP0560 | transketolase |
Trichomonas vaginalis | TVAG_038200 | transketolase, putative |
Trichomonas vaginalis | TVAG_212020 | transketolase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0664 | transketolase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.6170 this record | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.6170 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.6170 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.6170 this record | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2465 | Escherichia coli | non-essential | goodall |
CELE_F01G10.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F01G10.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F01G10.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F01G10.1 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_0109100 | Plasmodium berghei | Essential | plasmo |
TGME49_318310 | Toxoplasma gondii | Essentiality uncertain | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | increased (PATO:0000470) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | transketolase | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Haemophilus influenzae (strain 86-028NP) | 1-deoxy-D-xylulose-5-phosphate synthase | 625 aa | 22.8% | 518 aa | Compounds | References |
4 literature references were collected for this gene.